Jane Street Group LLC trimmed its holdings in Inogen, Inc. (NASDAQ:INGN – Free Report) by 83.1% during the third quarter, ...

Traditional airway clearance therapies can be time consuming and constraining with mixed results. SIMEOX 200 provides an ...

Inogen said regulators have cleared its SIMEOX 200 Airway Clearance Device to be used by U.S. patients with chronic respiratory diseases. The medical technology company said Monday that the Food and ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic ...

In recent years, the conversation around PFAS (per- and polyfluoroalkyl substances)-the so-called forever chemicals-has grown ...

No link was found between Competitive Bidding Program implementation and changes in supplemental oxygen use or clinical ...

Inogen was founded in part to help Bauerlein’s grandmother, Mae, who used supplemental oxygen therapy. Her grandmother had complained about the difficulties of constantly switching tanks and carrying ...

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA ...

Inogen, Inc. INGN recently announced the FDA 510(k) clearance for the SIMEOX 200 Airway Clearance Device. The clearance is likely to expand INGN’s ability to market the device and meet the ...

Inogen has received 510(k) clearance from the U.S. Food and Drug Administration for the Simeox 200 Airway Clearance Device, ...